Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1984-11-13
1988-01-19
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514534, 514535, 514544, 514557, 514561, 514562, 514568, 514570, 560 9, 560 11, 560 12, 560 19, 560 45, 560 46, 560 55, 560 64, 560 65, 562426, 562429, 562430, 562432, 562442, 562452, 562453, 562465, 562473, 562474, C07C14940, C07C147107, C07C14367, C07C10100, C07C15100, C07C14711, C07C14713, C07C10172
Patent
active
047205059
ABSTRACT:
Compounds having the formula: ##STR1## are antagonists of leukotrienes of C.sub.4, D.sub.4 and E.sub.4, the slow reacting substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic and anti-inflammatory agents.
REFERENCES:
patent: 4667055 (1987-05-01), Gillard et al.
D. M. Bailey et al., Ann Rpts. Med. Chem, 17, 203 (1982).
B. Samuelsson, Science 220, 568 (1983).
Belanger Patrice C.
Gillard John W.
Rokach Joshua
Ginsburg Paul H.
Lopez Gabriel
Merck Frosst Canada Inc.
Pfeiffer Hesna J.
Siegel Alan
LandOfFree
Leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-371857